Assessing the costs and cost-effectiveness of genomic sequencing

Kurt D. Christensen, Dmitry Dukhovny, Uwe Siebert, Robert C. Green

Research output: Contribution to journalReview article

50 Citations (Scopus)

Abstract

Despite dramatic drops in DNA sequencing costs, concerns are great that the integration of genomic sequencing into clinical settings will drastically increase health care expenditures. This commentary presents an overview of what is known about the costs and cost-effectiveness of genomic sequencing. We discuss the cost of germline genomic sequencing, addressing factors that have facilitated the decrease in sequencing costs to date and anticipating the factors that will drive sequencing costs in the future. We then address the cost-effectiveness of diagnostic and pharmacogenomic applications of genomic sequencing, with an emphasis on the implications for secondary findings disclosure and the integration of genomic sequencing into general patient care. Throughout, we ground the discussion by describing efforts in the MedSeq Project, an ongoing randomized controlled clinical trial, to understand the costs and cost-effectiveness of integrating whole genome sequencing into cardiology and primary care settings.

Original languageEnglish (US)
Pages (from-to)470-486
Number of pages17
JournalJournal of Personalized Medicine
Volume5
Issue number4
DOIs
StatePublished - Dec 10 2015

Fingerprint

Cost-Benefit Analysis
Costs and Cost Analysis
Pharmacogenetics
Disclosure
Health Expenditures
Cardiology
DNA Sequence Analysis
Primary Health Care
Patient Care
Randomized Controlled Trials
Genome
Delivery of Health Care

Keywords

  • Cost
  • Cost-effectiveness
  • Whole exome sequencing
  • Whole genomic sequencing

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Assessing the costs and cost-effectiveness of genomic sequencing. / Christensen, Kurt D.; Dukhovny, Dmitry; Siebert, Uwe; Green, Robert C.

In: Journal of Personalized Medicine, Vol. 5, No. 4, 10.12.2015, p. 470-486.

Research output: Contribution to journalReview article

Christensen, Kurt D. ; Dukhovny, Dmitry ; Siebert, Uwe ; Green, Robert C. / Assessing the costs and cost-effectiveness of genomic sequencing. In: Journal of Personalized Medicine. 2015 ; Vol. 5, No. 4. pp. 470-486.
@article{07c277b6b456426398665a233e5fc709,
title = "Assessing the costs and cost-effectiveness of genomic sequencing",
abstract = "Despite dramatic drops in DNA sequencing costs, concerns are great that the integration of genomic sequencing into clinical settings will drastically increase health care expenditures. This commentary presents an overview of what is known about the costs and cost-effectiveness of genomic sequencing. We discuss the cost of germline genomic sequencing, addressing factors that have facilitated the decrease in sequencing costs to date and anticipating the factors that will drive sequencing costs in the future. We then address the cost-effectiveness of diagnostic and pharmacogenomic applications of genomic sequencing, with an emphasis on the implications for secondary findings disclosure and the integration of genomic sequencing into general patient care. Throughout, we ground the discussion by describing efforts in the MedSeq Project, an ongoing randomized controlled clinical trial, to understand the costs and cost-effectiveness of integrating whole genome sequencing into cardiology and primary care settings.",
keywords = "Cost, Cost-effectiveness, Whole exome sequencing, Whole genomic sequencing",
author = "Christensen, {Kurt D.} and Dmitry Dukhovny and Uwe Siebert and Green, {Robert C.}",
year = "2015",
month = "12",
day = "10",
doi = "10.3390/jpm5040470",
language = "English (US)",
volume = "5",
pages = "470--486",
journal = "Journal of Personalized Medicine",
issn = "2075-4426",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - Assessing the costs and cost-effectiveness of genomic sequencing

AU - Christensen, Kurt D.

AU - Dukhovny, Dmitry

AU - Siebert, Uwe

AU - Green, Robert C.

PY - 2015/12/10

Y1 - 2015/12/10

N2 - Despite dramatic drops in DNA sequencing costs, concerns are great that the integration of genomic sequencing into clinical settings will drastically increase health care expenditures. This commentary presents an overview of what is known about the costs and cost-effectiveness of genomic sequencing. We discuss the cost of germline genomic sequencing, addressing factors that have facilitated the decrease in sequencing costs to date and anticipating the factors that will drive sequencing costs in the future. We then address the cost-effectiveness of diagnostic and pharmacogenomic applications of genomic sequencing, with an emphasis on the implications for secondary findings disclosure and the integration of genomic sequencing into general patient care. Throughout, we ground the discussion by describing efforts in the MedSeq Project, an ongoing randomized controlled clinical trial, to understand the costs and cost-effectiveness of integrating whole genome sequencing into cardiology and primary care settings.

AB - Despite dramatic drops in DNA sequencing costs, concerns are great that the integration of genomic sequencing into clinical settings will drastically increase health care expenditures. This commentary presents an overview of what is known about the costs and cost-effectiveness of genomic sequencing. We discuss the cost of germline genomic sequencing, addressing factors that have facilitated the decrease in sequencing costs to date and anticipating the factors that will drive sequencing costs in the future. We then address the cost-effectiveness of diagnostic and pharmacogenomic applications of genomic sequencing, with an emphasis on the implications for secondary findings disclosure and the integration of genomic sequencing into general patient care. Throughout, we ground the discussion by describing efforts in the MedSeq Project, an ongoing randomized controlled clinical trial, to understand the costs and cost-effectiveness of integrating whole genome sequencing into cardiology and primary care settings.

KW - Cost

KW - Cost-effectiveness

KW - Whole exome sequencing

KW - Whole genomic sequencing

UR - http://www.scopus.com/inward/record.url?scp=84992081328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992081328&partnerID=8YFLogxK

U2 - 10.3390/jpm5040470

DO - 10.3390/jpm5040470

M3 - Review article

AN - SCOPUS:84992081328

VL - 5

SP - 470

EP - 486

JO - Journal of Personalized Medicine

JF - Journal of Personalized Medicine

SN - 2075-4426

IS - 4

ER -